Characterization of the Antidiabetic Role of Parkinsonia aculeata (Caesalpineaceae)

Table 2

Serum total cholesterol, HDL-cholesterol, and triglycerides levels in normal and diabetic rats after subchronic treatment with HEPA.

Groups		Lipids concentration (mg/dL)
	Total Cholesterol	HDL-cholesterol	Triglycerides
NC	77.34 ± 2.45	36.3 ± 1.5	103.27 ± 5.50
NT125	81.72 ± 2.47	40.6 ± 1.2	83.68 ± 3.93^#
NT250	84.45 ± 5.83	41.2 ± 1.3	71.21 ± 4.18^#
DC	85.83 ± 7.72	32.4 ± 2.2	253.92 ± 18.77
DT125	73.26 ± 9.74	33.9 ± 4.1	78.38 ± 10.52^∗a
DT250	79.45 ± 3.92	37.7 ± 2.1	65.34 ± 8.68^∗a
DTI	83.81 ± 3.43	41.2 ± 1.8^∗	132.15 ± 16.29^∗a

Data represent the end of treatment (Day 16). NC: nondiabetic control (vehicle); NT125: nondiabetic treated with HEPA (125 mg/Kg); NT250: nondiabetic treated with HEPA (250 mg/Kg); DC: diabetic control (vehicle); DT125: diabetic treated with HEPA (125 mg/Kg); DT250: diabetic treated with HEPA (250 mg/Kg); DTI: diabetic treated with insulin. The values represent the mean ± S.E.M. (𝑛=6). One-way ANOVA with Tukey’s post hoc test. ^∗𝑃<.05 versus DC group; ^#𝑃<.05 versus NC group; ^a𝑃<.05 versus DTI group.